Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Tanabe

Showing results (111-120 of 272) with videos related to

Pageof 28
Sort By:
Annals of Gastroenterological Surgery|September 29, 2021
Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasmsYoshiki Murase, Atsushi Kudo, Keiichi Akahoshi, et al.
Surgery Today|December 6, 2023
Early-onset hepatic veno-occlusive disease after liver transplantation: an institutional experience and analysis of a literature-based cohortYutaka Endo, Masahiro Shinoda, Junki Maehara, et al.
Surgery Today|June 5, 2023
Long-term outcomes following ABO-incompatible living donor liver transplantation for acute liver failure: a single-center experience of over 20 yearsKazuya Hirukawa, Masahiro Shinoda, Yasushi Hasegawa, et al.
Anticancer Research|August 2, 2019
High-signal-intensity MR Image in the Hepatobiliary Phase Predicts Long-term Survival in Patients With Hepatocellular CarcinomaShun-Ichi Ariizumi, Daisuke Ban, Yuta Abe, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 10, 2010
Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasisTakao Mamiya, Ken Yamazaki, Yohei Masugi, et al.
Scientific Reports|May 10, 2023
MGMT is frequently inactivated in pancreatic NET-G2 and is associated with the therapeutic activity of STZ-based regimensKohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2021
A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasmsTomotaka Kato, Atsushi Kudo, Yuko Kinowaki, et al.
Annals of Surgical Oncology|December 28, 2013
EpCAM-targeted therapy for human hepatocellular carcinomaKousuke Ogawa, Shinji Tanaka, Satoshi Matsumura, et al.
Nature Communications|November 22, 2016
Autophagy controls centrosome number by degrading Cep63Yuichiro Watanabe, Shinya Honda, Akimitsu Konishi, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2016
Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasmEriko Katsuta, Atsushi Kudo, Takumi Akashi, et al.
Pageof 28

Showing results (111-120 of 272) with videos related to

Sort By:
Pageof 28
Annals of Gastroenterological Surgery|September 29, 2021
Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasmsYoshiki Murase, Atsushi Kudo, Keiichi Akahoshi, et al.
Surgery Today|December 6, 2023
Early-onset hepatic veno-occlusive disease after liver transplantation: an institutional experience and analysis of a literature-based cohortYutaka Endo, Masahiro Shinoda, Junki Maehara, et al.
Surgery Today|June 5, 2023
Long-term outcomes following ABO-incompatible living donor liver transplantation for acute liver failure: a single-center experience of over 20 yearsKazuya Hirukawa, Masahiro Shinoda, Yasushi Hasegawa, et al.
Anticancer Research|August 2, 2019
High-signal-intensity MR Image in the Hepatobiliary Phase Predicts Long-term Survival in Patients With Hepatocellular CarcinomaShun-Ichi Ariizumi, Daisuke Ban, Yuta Abe, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 10, 2010
Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasisTakao Mamiya, Ken Yamazaki, Yohei Masugi, et al.
Scientific Reports|May 10, 2023
MGMT is frequently inactivated in pancreatic NET-G2 and is associated with the therapeutic activity of STZ-based regimensKohei Yagi, Hiroaki Ono, Atsushi Kudo, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2021
A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasmsTomotaka Kato, Atsushi Kudo, Yuko Kinowaki, et al.
Annals of Surgical Oncology|December 28, 2013
EpCAM-targeted therapy for human hepatocellular carcinomaKousuke Ogawa, Shinji Tanaka, Satoshi Matsumura, et al.
Nature Communications|November 22, 2016
Autophagy controls centrosome number by degrading Cep63Yuichiro Watanabe, Shinya Honda, Akimitsu Konishi, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2016
Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasmEriko Katsuta, Atsushi Kudo, Takumi Akashi, et al.
Pageof 28